**Core Concept**
Platelet-activating factor (PAF) is a potent phospholipid mediator involved in various physiological and pathological processes, including inflammation, immune responses, and platelet aggregation. It activates platelets by binding to a specific receptor, leading to a cascade of intracellular signaling events.

**Why the Correct Answer is Right**
PAF is known to cause platelet aggregation by activating phospholipase C, which increases intracellular calcium levels and triggers the release of granules containing platelet-derived growth factor. This process also leads to the formation of platelet-platelet bridges, contributing to thrombus formation. Additionally, PAF causes vasoconstriction by stimulating the release of endothelium-derived contracting factors. However, PAF does not cause bronchodilation; in fact, it can induce bronchoconstriction by stimulating the release of histamine and other mediators from mast cells. PAF also transmits signals between cells by activating various receptors and influencing intracellular signaling pathways.

**Why Each Wrong Option is Incorrect**
**Option A:** Vasoconstriction is a known effect of PAF, which is mediated by the release of endothelium-derived contracting factors.
**Option C:** Platelet aggregation is a well-established consequence of PAF binding to its receptor on platelets.
**Option D:** PAF indeed transmits signals between cells by activating various receptors and influencing intracellular signaling pathways.

**Clinical Pearl / High-Yield Fact**
PAF plays a significant role in various inflammatory and immune responses, and its inhibition has been explored as a potential therapeutic strategy for conditions such as asthma and atherosclerosis.

**✓ Correct Answer: B. Bronchodilation. It does not cause bronchodilation, contrary to the other options.**